(Total Views: 380)
Posted On: 02/07/2022 1:53:21 PM
Post# of 1460
AVXL lost .15/share, as opposed to .12 last time. I assume that's the cost of clinical trials.
And another bogus "shareholder" suit seeking plaintiffs. Ho-hum. They are basing their "investigation" on -- tweets from Adam F. Now that really IS a LOL, given that he was totally wrong in his claim that AVXL had changed the endpoints 2 weeks before releasing data. In fact, it was just a delay (not AVXL's fault) in that website being updated over the holidays.
And of course -- how could that law firm announce the "suit" without knowing that? I call BS.
Oh yeah -- THERE ARE 6 ANALYST "STRONG BUY" or "BUY" RECOMMENDATIONS and NO "Hold" or "Sell" recommendations
And another bogus "shareholder" suit seeking plaintiffs. Ho-hum. They are basing their "investigation" on -- tweets from Adam F. Now that really IS a LOL, given that he was totally wrong in his claim that AVXL had changed the endpoints 2 weeks before releasing data. In fact, it was just a delay (not AVXL's fault) in that website being updated over the holidays.
And of course -- how could that law firm announce the "suit" without knowing that? I call BS.
Oh yeah -- THERE ARE 6 ANALYST "STRONG BUY" or "BUY" RECOMMENDATIONS and NO "Hold" or "Sell" recommendations
(2)
(0)
